Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:07 PM
NCT ID: NCT02519504
Description: Adverse event reporting includes all participants who attended the direct testing visit, regardless of if complete information was collected during this visit.
Frequency Threshold: 0
Time Frame: Adverse events were collected during the direct testing visit (Day 1). Due to the nature of this observational study, no adverse events were anticipated.
Study: NCT02519504
Study Brief: Intervention and Outcomes in Duarte Galactosemia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Children With Duarte Galactosemia (Cases) Pediatric subjects with Duarte galactosemia undergoing direct assessments of cognitive skills (memory, executive function, and auditory processing), communication processes (speech and language), physical development (including motor skills, coordination, and occurrence of tremors), and social-emotional development. 0 None 0 212 0 212 View
Unaffected Siblings (Controls) Pediatric subjects without Duarte galactosemia undergoing direct assessments of cognitive skills (memory, executive function, and auditory processing), communication processes (speech and language), physical development (including motor skills, coordination, and occurrence of tremors), and social-emotional development. 0 None 0 149 0 149 View
Serious Events(If Any):
Other Events(If Any):